Markets are Closed

SNY

Sanofi American Depositary Shares (Each repstg one-half of one)

Open

51.22

Previous Open

—

High

51.57

Previous High

—

Low

51.14

Previous Low

—

51.51

Previous Close

—

Volume

1,587,945

Previous Volume

—

Overview Tick Inspector

Company Profile

URL

http://www.sanofi.com

Description

Sanofi SA is healthcare company which is engaged in the research, development, manufacture and marketing of therapeutic solutions. It business activities include operations of specialty care, Established Prescription Products and vaccines operations.

Exchange

New York Stock Exchange

List Date

July 01, 2002

CEO

Olivier Brandicourt

Employees

106,566

Related Stocks

GSKNVSBMYJNJLLYPFEMRKTEVAXLV

Financials

Revenue

40.90B

Earnings

3.68B

48B

37B

26B

16B

2015

2016

2017

2018

Splits

September 29, 2013	0.20%
November 16, 2010	0.10%

Dividends

May 26, 2020	$1.21
May 31, 2019	$1.16
June 04, 2018	$1.86
June 07, 2017	$1.58
June 01, 2016	$1.63
June 02, 2015	$1.62
May 07, 2014	$1.91
May 06, 2013	$1.86
May 07, 2012	$1.76
May 11, 2011	$1.82
June 14, 2010	$1.63
April 20, 2009	$1.42
May 16, 2008	$1.51
July 03, 2007	$1.15
July 03, 2006	$0.91
July 01, 2005	$0.80
September 27, 2004	$0.03
June 01, 2004	$0.58
June 26, 2003	$0.49

Related News

Pfizer, Regeneron Give Update on Coronavirus Drug Development

Mar 18, 2020 @ 14:57

Pfizer (PFE) to jointly develop BioNTech's potential coronavirus vaccine. Regeneron (REGN) could start clinical studies of a COVID-19 therapy by this summer....

finance yahoo

Regeneron’s CEO Says We Could Have a Covid-19 Treatment ‘Quickly’

Mar 17, 2020 @ 18:26

“This could really slow down the number of people who needed really intensive respiratory therapy. This could go fairly quickly,” CEO Leonard Schleifer said in an interview with Barron’s....

finance yahoo

Sanofi to work on coronavirus vaccine

Feb 18, 2020 @ 15:41

Shares of Sanofi ADR were up 1% in trading on Monday after the French drugmaker announced plans to work on a vaccine for COVID-19, the new coronavirus that has sickened more than 73,000 people and led to the deaths of 1,873. The company said it will leverage previous work on a pre-clinical vaccine for severe acute respiratory syndrome (SARS) while it collaborates with the Biomedical Advanced Research and Development Authority (BARDA) on a COVID-19 vaccine. COVID-19 and SARS are both coronaviruses. A number of large drugmakers including GlaxoSmithKline and Johnson & Johnson have said they are also working on vaccines for the virus. Sanofi's stock is up 19% over the past year, while the S&P 500 has gained 23%....

finance yahoo

Sanofi Had Lost Some Mojo, New CEO Says. Now It’s Playing to Win.

Feb 06, 2020 @ 21:31

American depositary receipts of the pharmaceutical company rose after it reported better-than-expected quarterly results....

finance yahoo

Should Value Investors Pick Sanofi (SNY) Stock Right Now?

Jan 21, 2020 @ 14:35

Is Sanofi (SNY) a great pick from the value investor's perspective right now? Read on to know more....

finance yahoo

Cancer-fighting Peninsula biotech targets $100M IPO

Jan 17, 2020 @ 23:00

The Redwood City company raised $226 million in three venture rounds after its formation five years ago by Third Rock Ventures....

finance yahoo

Regeneron Stock Slides as French Drug Giant Sanofi Mulls Selling Stake

Dec 10, 2019 @ 12:47

Regeneron’s stock dropped 2.6% in pre-market trading after French drug giant Sanofi said it may sell its stake in the U.S. biotech leader....

finance yahoo

Are Investors Undervaluing Sanofi (SNY) Right Now?

Aug 06, 2019 @ 13:10

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks....

finance yahoo